Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 5, 1998, Pages 433-438

  Spinzi, G C ^a   Bierti, L ^b   Bortoli, A ^c   Colombo, E ^d   Fertitta, A M ^e   Lanzi, G L ^f   Venturelli, R ^g   Minoli, G ^a  

^a VALDUCE HOSPITAL   (Italy)

^b Policlinico di Milano   (Italy)

^c RHO HOSPITAL   (Italy)

^d Policlinico Garbagnate   (Italy)

^e Department of Internal Medicine   (Italy)

^f Macedonio Melloni Hospital   (Italy)

^g Policlinico Edolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; UREASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH BIOPSY; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; STOMACH ULCER;

EID: 0031806223     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00319.x     Document Type: Article

References (35)

1. National Insitute of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Tytgat GNJ. Review article: H. pylori infection and duodenal disease. J Intern Med 1992; 231: 199-203.
3. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
4. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716-27.
5. Van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection. A review of the world literature. Helicobacter 1996; 1: 6-19.
6. Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545-51.
7. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 1: 493-6.
8. Farup PG. Compliance with anti-ulcer medication during short term healing phase clinical trials. Aliment Pharmacol Ther 1992; 6: 179-86.
9. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short term, fore radication of H. pylori. Gastroenterology 1993; 104(4): A40(Abstract).
10. Misiewicz JJ, Harris AW, Bardham KL, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multicentre randomized trial. Gut 1996; 38: A1(Abstract).
11. Bazzoli F, Zagari RM, Fossi S, et al. Short term, low dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
12. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
13. Lind T, Velduyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole and two antimicrobials. The MACH 1 study. Helicobacter 1996; 1: 138-44.
14. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
15. Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337: 1486(Letter).
16. Nagata K, Takagi E, Tsuda M, et al. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother 1995; 39: 567-70.
17. Takimoto T, Ido K, Taniguchi Y, et al. Efficacy of lansoprazole in eradication of Helicobacter pylori. J Clin Gastroenterol 1995; 20(Suppl. 2): S121-4.
18. Damman HG, Richter G, Wolf N, et al. Influence of lansoprazole 15 and 30 mg and omeprazole 20 and 40 mg on meal-stimulated gastric acid secretion. Gut 1995; 37(Suppl. 2): A45-6(Abstract).
19. Ripke H, Fuder H, Kleistl P, et al. Intragastric pH under various dosage regimens of lansoprazole as compared to a reference treatment with omeprazole. Gut 1995; 37(Suppl. 2): A23(Abstract).
20. De Boer WA, Van Edden RJXM, Schade RWB, et al. 4-Day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 1778-82.
21. Harris A, Misiewicz JJ. Treating Helicobarter pylori - The best is yet to come? Gut 1996; 39: 781-3.
22. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996; 10: 1029-33.
23. Hirschowitz BI, Mohnen J, Shaw S. Omeprazole with amoxycillin alone or in combination with clarithromycin to treat H. pylori. Gastroenterology 1995; 90: 1579(Abstract).
24. Soll AH. Medical treatment of peptic ulcer disease. J Am Med Assoc 1966; 275: 622-9.
25. Misiewicz JJ, Tytgat GNY, Goodwin CS, et al. The Sidney System: a new classification of gastritis. Working party reports. Sidney, Australia: World Congress of Gastroenterology: 1990: 1-10.
26. Navratil E, Soule JC, Rousseau M, et al. Comparison of immunohistochemistry and histology for the diagnosis of Helicobacter pylori infection after treatment. Gut 1995; 37(Suppl. 1): A35.
27. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double blind trial. Am J Gastroenterol 1993; 88: 1860-4.
28. Lim AG, Walker C, Chambers S, Gould SR. Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. Aliment Pharmacol Ther 1997; 11: 537-40.
29. Logan RPH, Gummet PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
30. Weldon MJ, Broadbent A, Chamner S, et al. A 7-day Helicobacter pylori treatment using clarithromycin, omeprazole and bismuth chelate. Aliment Pharmacol Ther 1996; 10: 279-83.
31. Wurzer H, Rodrigo L, Archambault A, et al. Short course therapy with amoxicillin, clarithromycin triple for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Gut 1996; 39(Suppl. 2): A38.
32. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
33. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
34. Jaup BH, Norr BY. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
35. Lam SK, Ching CK, Lai KC, et al. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut 1997; 41: 43-8.